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Abstract
Integration of the HIV-1 cDNA into the human genome is catalyzed by the viral integrase (IN) protein. Several studies have
shown the importance of cellular cofactors that interact with integrase and affect viral integration and infectivity. In this
study, we produced a stable complex between HIV-1 integrase, viral U5 DNA, the cellular cofactor LEDGF/p75 and the
integrase binding domain of INI1 (INI1-IBD), a subunit of the SWI/SNF chromatin remodeling factor. The stoichiometry of the
IN/LEDGF/INI1-IBD/DNA complex components was found to be 4/2/2/2 by mass spectrometry and Fluorescence Correlation
Spectroscopy. Functional assays showed that INI1-IBD inhibits the 39 processing reaction but does not interfere with specific
viral DNA binding. Integration assays demonstrate that INI1-IBD decreases the amount of integration events but inhibits by-
product formation such as donor/donor or linear full site integration molecules. Cryo-electron microscopy locates INI1-IBD
within the cellular DNA binding site of the IN/LEDGF complex, constraining the highly flexible integrase in a stable
conformation. Taken together, our results suggest that INI1 could stabilize the PIC in the host cell, by maintaining integrase
in a stable constrained conformation which prevents non-specific interactions and auto integration on the route to its
integration site within nucleosomes, while LEDGF organizes and stabilizes an active integrase tetramer suitable for specific
vDNA integration. Moreover, our results provide the basis for a novel type of integrase inhibitor (conformational inhibitor)
representing a potential new strategy for use in human therapy.
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Introduction
During the early events of viral replication the RNA genome is
converted into its cDNA copy which then, upon interaction with
cellular and viral proteins, generates the pre-integration complex
(PIC). Cellular trafficking along the microtubule network trans-
ports the PIC to the nuclear envelope. The lentivirus subfamily
PICs exhibit karyophilic properties which enable them to enter the
nucleus through the nuclear pore. To establish a productive
infection, the viral cDNA must subsequently be integrated into the
host genome by the integrase protein (IN), which is a permanent
component of the virion and the PIC. IN performs several
important steps in the life cycle of retroviruses. It was shown to be
involved in several steps of HIV-1 replication, such as uncoating
[1], reverse transcription [2], nuclear import [3], chromatin
targeting [4] and integration [5]. Viral components such as IN
cannot perform all these functions by themselves and need to
recruit host cell proteins to efficiently carry out the different
activities. The molecular details and temporal sequence of these
processes, and particularly the role of cellular co-factors, remain
largely unknown.
The IN enzyme consists of three structural and functional
domains, namely the N-terminal zinc binding domain (residues 1–
50), the central catalytic core domain (CCD; residues 50–212)
containing the D, D, E triad that coordinates divalent ions and the
C-terminal domain (residues 213–288). A systematic study of
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mutants in the catalytic core identified a mutation (F185K) which
greatly increases its solubility [6]. This mutant was used for high
resolution structural studies. Several partial structures of HIV-1 IN
have been solved, namely the CCD domain alone [7–10], as well
as the CCD domain combined with the C-terminal domain [11]
or the N-terminal domain [12] and finally, the CCD in complex
with the IN binding domain of LEDGF [13]. Structures of IN
from other retroviruses have also been solved [14]. In these
structures, the catalytic core is organized into a highly conserved
dimer except for the IN encoded by the Rous associated virus
type-1 [15], whereas the position of the N-terminal and C-terminal
domains relative to the catalytic core domain is extremely variable
(Fig. S1). Recently, the structures of two functional integration
units have been solved, namely the crystallographic structure of
the Prototype Foamy Virus (PFV) IN/DNA complex [16] and the
cryo Electron Microscopy (cryo-EM) structure of the HIV-1 IN/
LEDGF/DNA complex [17]. To validate the comparison between
the two structures we solved the EM structure of the PFV IN
tetramer (Fig. S2 and methods S1). The X-Ray structure of the
PFV IN could be readily fitted in the envelope showing that the
overall arrangement of the IN domain does not depend of the
method used (EM and X-ray). Both structures showed that the
functional unit is composed of an IN tetramer. The comparison of
the two structures revealed a different organization of the
monomers in the tetrameric unit (Fig. S3). Moreover, most of
the residues showed to be important for DNA binding and/or
39processing in the HIV-1 integrase model constructed using the
PFV IN structure [18] are also in interaction with DNA in our EM
model [17].Taken together, the data reveal a high flexibility in the
linkers between the IN domains as well as in their oligomeric
organization. This inherent flexibility explains the propensity of IN
to interact with multiple partners and to intervene in numerous
biological functions by exposing and reshaping interaction surfaces
[19–21]. The final arrangement of the domain is probably strongly
dependent of the interaction with protein co-factors and IN
function in the infected cell (microtubule migration, nuclear
internalization, chromatin targeting and integration). Several
cellular co-factors have been shown to be important for HIV-1
infection and to interact with HIV-1 IN [22–26]. Among them,
the INtegrase Interactor protein 1 (INI1) which is a homolog of
yeast SNF5, the core component of the SWI/SNF chromatin
remodeling complex [27], and the Lens Epithelium-Derived
Growth Factor (LEDGF) [28], a transcriptional co-activator.
The function of LEDGF in HIV-1 infection is to target IN to
chromosomes of infected cells [29]. Its expression is required for
proviral integration and subsequent production of HIV-1 virions
[30]. At the structural level, the interaction with LEDGF was
shown to produce an IN active form by maintaining a stable HIV-
1 IN tetramer [17].
INI1 was the first protein shown to interact with IN [27]. The
385 residue long INI1, contains a C-terminal SNF5 homology
domain with 3 highly conserved sequence motifs: repeat 1 and 2
and a coiled-coil motif (Fig. S4). Repeat 1 was found to be
necessary and sufficient to bind to IN [31]. The role of INI1 in the
HIV-1 replication cycle remains controversial, but it has been
clearly established that it acts both on the early and late stages of
viral infection, probably by distinct mechanisms. In the late stage,
INI1 may facilitate proviral transcription by enhancing Tat
function [32–36]. Indeed, INI1 could act as a regulating factor
to initiate one of two mutually exclusive transcription programs
after integration, namely post-integration latency or high-level,
Tat-dependent gene expression [37]. It has also been shown that
over-expression of the INI1 integrase binding domain in the cell
inhibits HIV-1 assembly by specifically binding to viral gag-pol
protein [38]. Finally, INI1 was shown to be incorporated in
mature virions with a stoichiometry of 1 INI1 for 2 IN molecules
[39] and to incorporate SAP18 HDAC complex into virions [40].
INI1 has been shown to both increase [38,41,42] and inhibit [43]
viral replication. In vitro experiments on reconstituted nucleosomes
have demonstrated that purified SWI/SNF complexes stimulate
viral DNA integration by restoring the DNA accessibility to IN via
nucleosome remodeling [41].
In order to clarify the INI1 - mediated inhibition and/or
activation functions in the early stage of HIV-1 infection, we
analyzed the structure-function relationships of a quaternary
complex comprising the full length wild type HIV-1 IN, the full
length wild-type LEDGF, the INI1 IN binding domain (174–289)
(INI1-IBD) and viral U5 DNA. We first showed that the IN/
LEDGF complex performs concerted integration more efficiently
than isolated IN molecules and with a higher fidelity regarding the
structure of the integrated DNA expected for HIV-1. In the
presence of INI1-IBD, integration events are decreased whereas
the formation of integration by-products (donor/donor and linear
FSI) are strongly reduced when compared to IN alone or to the
IN/LEDGF complex. Fluorescence anisotropy measurements
showed that the dissociation constants of IN/LEDGF and IN/
LEDGF/INI1-IBD for U5 vDNA remain in the same order of
magnitude, indicating that viral DNA interaction is not impaired
by the presence of INI1-IBD. Analysis of the 39 processing activity
demonstrated that INI1-IBD, when bound to the IN/LEDGF
complex, inhibits the 39 processing reaction. Mass spectrometry
and FCS analysis showed that 2 INI1-IBD, 2 LEDGF and 2 U5
vDNA molecules interact tightly with an IN tetramer. Finally, the
structural analysis by cryo-EM of the IN/LEDGF/DNA [17] and
INLEDGF/INI1-IBD/DNA complexes revealed the binding sites
of LEDGF, INI1-IBD and U5 vDNA on the IN tetramer. INI1-
IBD interacts with IN on the opposite side of the LEDGF binding
site and within the target DNA interaction region, locking IN in
a stable constrained conformation. Taken together, our data show
that INI-IBD steadies the highly flexible IN protein in a compact
stable conformation. This suggests that the role of the full length
INI1 in the early stage of infection could be to stabilize IN and
prevents its inter-domain flexibility, thus preventing non-specific
interaction and auto integration on the route to its specific
nucleosome targets, while LEDGF organizes and stabilizes an
active IN tetramer suitable for specific vDNA integration.
Results
Purification and Characterization of the IN/LEDGF/INI1-
IBD Complex
In order to study the effect of INI1 on the structure and function
of IN we intended to add a fragment of INI1 onto the previously
characterized, highly soluble and active IN/LEDGF complex.
The method used to produce the complexes yields a soluble,
homogeneous and active entity. This is in sharp contrast with most
of the earlier work on full length integrase which is known to be
prone to aggregation. A soluble fragment of INI1 containing the
bona-fide integrase binding domain was identified and produced
using a structural genomic strategy. The amino acid sequence of
INI1 was analyzed by a combination of programs, including
multiple alignment [44] and various prediction tools [45] to define
domain limits. A total of 16 fragments were cloned in fusion with 3
different affinity tags (MBP, GST, HIS) and were tested for
expression and solubility. The INI1 fragment spanning residue
174 to 289 in fusion with 6 histidines was selected (Fig. S4).
Full length IN, full length LEDGF and the INI1 (174–289)
(INI1-IBD) fragment were purified separately and solubilized
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using high salt and CHAPS. The IN/LEDGF/INI1-IBD complex
was formed upon removal of the solubilizing agents by dialysis and
was purified to homogeneity by affinity chromatography and gel
filtration which showed a sharp and symmetric peak (Fig. S5A).
The stoichiometry of the partners was determined by High-Mass
MALDI ToF mass spectrometry analysis [46]. Control experi-
ments identified the mass of the three components: IN
(MH+= 32.8 kDa), LEDGF (MH+= 60.4 kDa) and His6-INI1-
IBD (MH+= 17.2 kDa) (Fig. S5B). In a second step, the purified
complex was chemically cross-linked prior to mass spectrometry.
Trace amount of several protein and complexes were detected:
[INI1-IBD] (MH+= 17.8 kDa), [IN?IN] (MH+= 64.8 kDa) and
[LEDGF?LEDGF] (MH+= 122.6 kDa,), but the mass of the major
species corresponded to [4IN?2LEDGF?2INI1-IBD]
(MH+= 283.4 kDa) (Fig. S5C). Higher molecular weight com-
plexes in the range between 500–1000 kDa were not detected,
indicating that the complexes did not aggregate. These experi-
ments show that a stable complex is formed between the
previously characterized [4IN?2LEDGF] complex which incorpo-
rates 2 molecules of INI1-IBD.
In vitro DNA Binding Properties
Evidence for the binding of two viral U5 DNA duplexes to
the IN/LEDGF complex. To determine the number of viral
U5 DNA duplexes bound to the IN/LEDGF complex, we used
Fluorescence Correlation Spectroscopy (FCS) with viral U5 DNA
duplex (40 bp) modified on one of its 59 ends by Texas red (TXR).
In the absence of IN/LEGDF, the autocorrelation function G(t) of
the U5 vDNA-TXR duplexes indicated a single diffusion time (D1)
of 97+/23 mm2Ns21 (Fig. S6A), fully consistent with the diffusion
of a DNA duplex of 26 kDa [47].The distribution of brightness
(Fig. S6B), obtained from a large number of measurements (n <
60), was nearly mono-disperse with a median value of 0.77+/
20.07 kHz per U5 vDNA-TXR duplex. Addition of IN/LEDGF
to the U5 vDNA-TXR duplex solution shifted the autocorrelation
curve to longer diffusion times (Fig. S6C), indicating an increase
in the molecular weight of the diffusing species, in line with an
interaction of U5 vDNA-TXR duplex with IN/LEDGF. More-
over, the observed increase in the Y-axis intercept of the
autocorrelation curve, which is inversely proportional to the
number of diffusing species, indicated a decrease in the total
number of diffusing species (Fig. S6A). This suggests that more
than one U5 vDNA-TXR duplex interacts with each IN/LEDGF
complex. According to the binding experiments (see below),
a fraction of the U5 vDNA-TXR duplexes in solution is likely to
be not bound to the IN/LEDGF complexes in the FCS conditions.
Therefore, to take into account the presence of both free and
bound vDNA-TXR molecules, the autocorrelation curves were
fitted by a two-population model (Eq. 2 in methods S1). To
limit the number of variables in the fitting process, the value of the
correlation time tD1 for the free molecules was fixed, using the
aforementioned value obtained with U5 vDNA-TXR duplex
alone. From the fit, the value of the diffusion constant of the U5
vDNA-TXR/IN/LEDGF complexes (D2) was found to be 51+/
20.2 mm2?s21, suggesting that the molecular weight of the
complexes is about 300 kDa. Moreover, the ratio of brightness
between the complex of U5 vDNA-TXR duplex with IN/LEDGF
and free U5 vDNA-TXR duplex (B2/B1) was found to be 1.96+/
20.62, further indicating that the IN/LEDGF complex binds two
U5 vDNA-TXR duplexes. Finally, the ratio (N2/N1) (ratio
between the number of U5 vDNA-TXR/IN/LEDGF complexes
and the number of free U5 vDNA-TXR duplexes) was 1.30+/
20.07, a value very close to that (1.25) calculated from the Kd
value determined by fluorescence anisotropy (see below). Taken
together, these results show that two U5 vDNA duplexes are
bound to one IN/LEDGF complex. Moreover this experiment
demonstrates that the IN/LEDGF complex is homogenous and
does not aggregate in the presence of DNA.
Determination of binding constants by fluorescence
anisotropy. The binding constants of the viral U5 DNA duplex
for the IN/LEDGF and IN/LEDGF/INI1-IBD complexes were
determined by fluorescence anisotropy. The viral U5 DNA duplex
(40 bp) of the same sequence as for the FCS experiments was
modified at one of its 59ends by 6-Carboxyfluorescein (6FAM). As
expected, an increase in the fluorescence anisotropy was observed
upon addition of increasing concentrations of protein to a fixed
concentration of DNA. The dissociation constant (Kd) was
calculated using the Scatchard equation rewritten to fit the
anisotropy data [48] as described in the methods S1. A
stoichiometry of 2 U5 vDNA duplexes per IN/LEGDF or IN/
LEDGF/INI1-IBD complex was assumed, based on the FCS
experiments. The Kd values found for the IN/LEDGF and IN/
LEDGF/INI1-IBD complexes are respectively 10.6+/20.5 nM
and 35+/24 nM (Fig. 1A, B). These values are similar to those
found in previous studies [49].To assess the specificity of the
binding sites for U5 vDNA duplex, competition experiments with
an excess of non-fluorescent specific and non-specific DNA
duplexes were performed. While the latter induced no shift in
the titration curve, excess of non-fluorescent specific U5 vDNA
duplex was found to shift the binding curve, in line with
a competition of fluorescent and non-fluorescent specific U5
vDNA duplex for the binding sites. This indicates the specificity of
both IN/LEDGF and IN/LEDGF/INI1-IBD complexes for U5
vDNA duplexes. Taken together these data indicate that the IN/
LEDGF complexes, with and without INI1-IBD, specifically bind
the U5 DNA complexes with binding constants that differ only by
a factor of three.
Influence of INI1-IBD and LEDGF on the 39 Processing
Reaction
To investigate the 39-processing reaction catalyzed by the IN/
LEDGF and IN/LEDGF/INI1-IBD complexes, we used HIV-1
U5 viral DNA duplex with the same sequence as for the FCS and
fluorescence anisotropy experiments, but labeled at one of its
39ends by 6-FAM. The 39 processing reaction with this DNA
duplex releases a fluorescent GT-FAM dinucleotide, which results
in a decrease of the fluorescence anisotropy [50]. The release of
GT-FAM was monitored as a function of time for the IN/LEDGF
and IN/LEDGF/INI1-IBD complexes (Fig. 1C). The results
clearly show that the 39 processing reaction is fully inhibited in the
ternary complex (IN/LEDGF/INI1-IBD), indicating that INI1-
IBD does not affect DNA binding but protects the 39ends of the
viral DNA from endonucleotidic cleavage by IN. This result has
been confirmed using a gel based 39 processing assay (Fig. S7).
Influence of INI1-IBD and LEDGF on the Integration
Reaction
The concerted integration reaction performed under standard
conditions demonstrates that the recombinant IN/LEDGF
complex performs this reaction in a highly efficient way. Half
Site Integration (HSI), Full Site Integration (FSI) and donor-donor
(d/d) integration products were detected by gel electrophoresis and
showed that the global integration efficiency was higher for the
IN/LEDGF complex than for isolated IN molecules (Fig. 2A).
Specific cloning and quantification of the circular FSI products
attested that the IN/LEDGF complex catalyses 2 to 10 times more
concerted integration events than isolated IN molecules (Fig. 2B).
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In addition the structure of the integrated viral DNA was analyzed
by sequencing the cloned circular FSI products. The sequences
clearly show that the integration reaction catalyzed by the IN/
LEDGF complex is closer to the expected physiological reaction
than IN alone since it produced two times more HIV-1-specific
5 bp staggered cuts of the target DNA (Fig. 2C). To investigate
the effect of INI1 on the integration reaction, a comparative
analysis of the reaction products was performed with the IN, IN/
LEDGF or IN/LEDGF/INI1-IBD complexes. In the presence of
INI1-IBD, a reduction of the integration events was observed as
well as an inhibition of by-product formation such as d/d or linear
FSI molecules (Fig. 2D). The integration activity detected in the
presence of INI1-IBD results from a competitive displacement of
INI1-IBD by tDNA as shown in Fig. 2E. In vitro, this equilibrium
is probably strongly displaced towards the quaternary IN/
LEDGF/INI1-IBD/vDNA complex and would be slowly dis-
placed towards the integrated products as the IN/LEDGF/vDNA
complex is used and INI1-IBD displaced by the tDNA. Altogether,
in the presence of INI1-IBD, integration occurs with reduced
kinetics compared to IN alone or to the IN/LEDGF complex, but
with strongly reduced by-products formation (donor/donor or
linear FSI).
Cryo-electron Microscopy Structure of the IN/LEDGF/
INI1-IBD/vDNA Complex
To better understand the mechanism by which INI1-IBD
inhibits the 39 processing reaction and by-products formation in
the integration reaction, we determined the structure of the IN/
LEDGF/INI1-IBD/DNA complex by a two-step electron micros-
copy strategy. We first imaged the purified IN/LEDGF/INI1-IBD
complexes after negative staining in order to determine a low
resolution model from which the position of INI1-IBD can be
deduced by comparison with previous data on IN/LEDGF. Then
we imaged frozen hydrated, unstained IN/LEDGF/INI1-IBD/
vDNA particles to solve a higher resolution structure of the full
complex.
The image analysis of negatively stained single particles by
correlation averaging methods revealed views about 14–15 nm in
size, several of which showed a clear 2-fold symmetry. Particles of
similar size and symmetry were previously observed for the IN/
LEDGF complex [17], thus indicating that the addition of INI1
does not modify the oligomerization state of the IN-containing
complexes. A 3-D model of the IN/LEDGF/INI1-IBD complex
was determined and the difference map with the IN/LEDGF
complex showed a positive difference in the region where the
target DNA was shown to interact [17] (Fig. 3A).
The IN/LEDGF/INI1-IBD complex was then incubated with
a tenfold molar excess of the 21-mer U5-substrate. The particles
were homogeneous in size and uniformly distributed on the grid. A
dataset of 12781 images of unstained, frozen hydrated IN/
LEDGF/INI1-IBD/vDNA complexes was recorded and analyzed
independently from any previous model. A 3-D model was built
using the angular reconstitution protocol [51], followed by a search
for a two-fold axis to impose a symmetry that was observed in all
IN/LEDGF complexes analyzed so far. The volume enclosed by
the 3-D model shown in Fig. 3B is consistent with the
stoichiometry of 4 IN, 2 LEDGF and 2 INI1-IBD molecules
(,283 kDa) determined by mass spectrometry. A resolution of
18 A˚ was obtained according to the Rosenthal and Henderson
criteria [52] (Fig. S9).
The maps of the IN/LEGDF/DNA [17] and the IN/LEGDF/
INI1-IBD/vDNA complexes could be readily superimposed
(Fig. 4A). The existing atomic structures of IN (catalytic core,
N-and C-terminal domains) and of the IN-Binding Domain of
LEDGF were pre-positioned as determined previously in the IN/
LEGDF/DNA model. They were further refined by normal mode
flexible fitting (NMFF) and structure idealization. The fitting
parameters were chosen in a way that does not modify the fold of
the protein domains, as described in the methods S1. The
position of the IN tetramer was found to be unchanged upon
addition of INI1-IBD. A density difference map was then
calculated between the cryo-EM map and the fitted atomic
structures, in order to reveal the positions of INI1-IBD, LEDGF
and DNA (Fig. 3C). The difference map shows three groups of
additional densities, corresponding to the IN interaction partners
(INI1-IBD, LEDGF, vDNA). A saddle-shaped density is observed
on the top of the IN dimers (pink density in Fig. 3C), which
corresponds to INI1-IBD since its position is identical to the one
found in the absence of DNA (Fig. 3A). A second group of
additional densities is detected within the viral DNA binding sites,
corresponding to bound DNA molecules. The difference map
reveals rod-like structures consistent with the size and shape of
DNA molecules (yellow densities in Fig. 3C). In the presence
of INI1-IBD, two U5 vDNA duplexes could be fitted in the
electron density map. Interestingly, U5 viral DNA duplexes are
rotated by about 40u in the INI1-IBD containing complex, as
compared to the IN/LEDGF/DNA strand transfer model [17]
(Fig. 4B). The third group of additional densities is located at the
Figure 1. In vitro functional tests. A–B: Determination by fluorescence anisotropy of the dissociation constant of viral DNA to IN/LEGDF and IN/
LEDGF/INI1-IBD. A: Titration curve of viral DNA by the IN/LEDGF complex in the absence (square, continuous line) or in the presence of an excess of
non-fluorescent viral DNA (circles, dotted line) and non-fluorescent non-specific DNA (triangles, dashed line). B: Same as A for the IN/LEDGF/INI1-IBD
complex. Lines correspond to the fits of equation 8 in methods S1 to the data. C: 39 processing reaction followed by fluorescence anisotropy. The
fraction of released GT as a function of time is shown in blue for the IN/LEDGF complex and in red for the IN/LEDGF/INI1-IBD complex.
doi:10.1371/journal.pone.0060734.g001
HIV-1 IN/LEDGF/INI1/DNA Structure-Function Studies
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e60734
Figure 2. Comparative analysis of the in vitro concerted integration catalyzed by HIV-1 IN, HIV-1 IN/LEDGF and HIV-1 IN/LEDGF/
INI1-IBD complex. A. In vitro integration profiles of HIV-1 IN and HIV-1 IN/LEDGF complexes. Concerted integration assay was performed using 0.1
to 12.5mM IN or IN/LEDGF complex (concentration are normalized to IN monomers), 150 ng of acceptor plasmid, 15 ng of radioactively labelled and
processed donor DNA. The reaction products were loaded on 1% agarose gel. The position and the structure of the different products obtained after
half-site (HSI), full-site (FSI) and donor/donor (d/d) integration are reported. B. Full site integration activity. The circular FSI products obtained in (A)
were quantified by cloning in bacteria and reported as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones [62]. C.
Structure of the integration products. One hundred circular FSI integration products were isolated in condition where the concerted integration assay
was performed with 12.5 mM of IN or IN/LEDGF complexes and were sequenced as reported in the materials and methods section. The number of
correct 5 bp duplication, deletions and other structures are reported as percentages. All values reported are the mean 6 standard deviation (error
bars) of three independent sets of experiments. D. Effect of INI1 on the integration profile. The assay was performed and reported as in (A) using
12.5mM IN, IN/LEDGF or IN/LEDGF/INI1-IBD complex (in IN monomers). A quantification of the gel showing the strong decrease in linear fsi and dd
product is shown in figure S8. E Proposed equilibrium between the different complexes involved. In the presence of tDNA, INI1 is slowly displaced
from the IN/LEDGF/INI1-IBD/vDNA complex and the integration reaction can occur to produce specific integration products.
doi:10.1371/journal.pone.0060734.g002
HIV-1 IN/LEDGF/INI1/DNA Structure-Function Studies
PLOS ONE | www.plosone.org 5 April 2013 | Volume 8 | Issue 4 | e60734
HIV-1 IN/LEDGF/INI1/DNA Structure-Function Studies
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e60734
bottom of the structure and corresponds to the LEDGF protein
which contributes to stabilize the complex (grey density in
Fig. 3C). The fitting of the atomic models into the IN/LEDGF/
INI1-IBD/vDNA map was then further refined in order to reveal
more clearly the positions of LEDGF, INI1-IBD and vDNA
(Fig. 3D). The atomic structures fitted into the cryo-EM map
showed that the complex contains 4 IN, 2 LEDGF, 2 INI1-IBD
and 2 U5 vDNA molecules, confirming the mass spectrometry and
FCS data. The structure of the complex is organized around two
asymmetric IN dimers. The first dimer, formed by two monomers
(A1, B1), shows different positioning of their respective N and C
terminus and is related to the second dimer (A2, B2) by a twofold
symmetry (Fig. 5). The INI1-IBD dimer interacts on the top of the
IN tetramer and contacts mainly the N and C-termini of the two
IN B monomers (NtB1, NtB2, CtB1, CtB2). A small lateral
extension of INI1-IBD reaches the C-terminus of the two A
monomers (CtA1, CtA2), in close proximity with the viral U5
DNA duplex (Fig. 5).
Discussion
HIV-1 IN is the platform protein present in all steps of the
retroviral cycle involving the preintegration complex (PIC). IN
forms the structural core of the PIC and is most probably involved
in PIC migration along microtubules [53], transfer to the nucleus
[54], as well as chromatin targeting [55] and integration.
Comparison of known structures of retroviral INs shows the high
conformational flexibility of its different domains, depending on
the virus type and the presence of interacting host proteins. This
conformational flexibility explains the ability of IN to interact with
multiple partners and to exert multiple biological functions. To
gain further insight into the regulation of IN functions by host
factors, we investigated the structures and interactions of IN with
the cellular LEDGF and INI1-IBD proteins, as well as their
impact on IN activities.
The IN/LEDGF complex was established to be composed of 4
IN and 2 LEDGF molecules [17] but little information was
available on the binding of viral DNA. Based on a brightness
analysis, FCS shows that two U5 viral DNA (vDNA) duplexes can
bind to this complex. Furthermore, the diffusion constant
measured by FCS for the IN/LEDGF/vDNA complex (51
mm2.s-1) is consistent with the theoretical diffusion constant of
the IN4-LEDGF2-vDNA2 complex (37.2 mm2.s-1), calculated from
its dimensions (15.5 nm614 nm610 nm) determined by EM.
Thus, FCS confirms that IN4-LEDGF2-vDNA2 is the major
complex in solution. The addition of INI1-IBD to IN/LEDGF led
to a stable IN/LEDGF/INI1-IBD complex which indicates that
both cellular proteins can bind simultaneously to IN. By further
adding U5 vDNA duplex, an IN/LEDGF/INI1-IBD/vDNA
complex was formed thus demonstrating that neither host factor
interferes with vDNA binding. Fluorescence anisotropy confirms
that U5 vDNA duplexes bind specifically to both IN/LEDGF and
IN/LEDGF/INI1-IBD complexes, with affinities of 11 and
35 nM, respectively. Thus, INI1-IBD only weakly affects the
binding of vDNA to the complex.
The Cryo-EM structure of the IN/LEDGF/INI1-IBD/vDNA
complex fully agrees with the stoichiometry of 4 IN, 2 LEDGF, 2
INI1-IBD and 2 vDNA molecules determined by FCS and mass
spectrometry and furthermore reveals the interaction sites of INI1-
IBD, LEDGF and vDNA with IN (Fig. 5, 6). INI1-IBD interacts
mainly with the C-terminal domains of two IN monomers (CtA
and CtB) and with the N-terminal domain of monomer B (NtB). In
this position INI1-IBD does not sterically interfere with the DNA
binding site of IN which appears occupied in the 3-D model as
predicted by the binding studies.
The overall domain organization of the IN tetramer in complex
with DNA, LEDGF and INI1-IBD is similar to of the one found in
the absence of INI1 [17] except for conformational changes in the
N- and C-terminal parts of IN due to their interactions with INI1-
IBD. These interactions stabilize an IN conformation that is not
compatible with the 39 processing and integration reaction. In
particular, the reorientation of the N- and C-terminal parts of IN
induces a rotation of about 40u of the viral DNA as compared to
the previously studied 39 processing complex (17) (Fig. 4). The
DNA orientation in the IN/LEDGF/INI1-IBD/vDNA complex is
thus intermediate to those in the 39 processing and integration
complexes (Fig. 7).
These structures are fully consistent with the 39 processing and
concerted integration assays and help to understand the effect of
LEDGF and INI1-IBD on the enzymatic activities of IN. In
agreement with the structure showing a catalytic inactive
conformation, our activity experiments show that the 39 processing
reaction is strongly inhibited by the binding of INI1-IBD to the
IN/LEDGF complex. Comparison of the structures of the IN/
LEDGF/DNA and IN/LEDGF/INI1-IBD/vDNA complexes
shows that the conformational changes necessary to bring the 39
end of the viral U5 DNA to the IN active site are prevented by
INI1-IBD, which sits in the target DNA (tDNA) binding cleft and
locks the IN tetramer in a stable constrained conformation. These
data provide a structural basis for a new inhibition strategy that
could be used in human therapy. These observations also strongly
support the ability of IN to adapt its structure, in order to carry out
specific functions directed by the partner protein. In vitro
integration assays showed that the activity of the IN/LEDGF
complex is strongly enhanced compared to IN alone, especially in
low protein concentrations such as found in vivo. Furthermore the
sequencing of the full-site integration products showed that the
proportion of correctly integrated species with the characteristic
5 bp stagger is higher in the presence of LEDGF. These
observations further strengthen the role of LEDGF as a molecular
chaperone that organizes the IN tetramer in a functional and
highly reactive species. Integration assays were also realized in the
presence of INI1-IBD by providing 39 pre-processed vDNA
duplexes to overcome the inhibition of the 39processing reaction
experienced in the presence of INI1-IBD. The presence of INI1-
IBD leads to reduced integration events and to a higher in-
tegration specificity since unwanted by-products such as linear full
site integration or donor/donor integration are strongly reduced.
These effects can be clearly explained by the IN/LEDGF/INI1-
IBD/vDNA structure, which shows that INI1-IBD sits in the
target DNA (tDNA) binding site, competing with the binding of
Figure 3. Cryo-EM structure. A. Negatively stained structures of the IN/LEDGF (blue) and IN/LEDGF/INI1-IBD (gold) complexes. The difference
between the two maps representing the position of INI1-IBD is in red. B. Cryo-EM structure of the IN/LEDGF/INI1-IBD/DNA complex represented by
three perpendicular views. C. Difference map calculated by subtracting the density corresponding to the fitted atomic models of IN and LEDGF from
the IN/LEDGF/INI1-IBD/DNA cryo-EM map. The differences, corresponding respectively to INI1-IBD, DNA and LEDGF, are represented in violet, yellow
and grey. D. Three perpendicular views of the IN/LEDGF/INI1-IBD/DNA complex: INI1-IBD is in violet, LEDGF in grey and viral DNA in yellow. The fitted
IN model is represented as molecular surface. For both IN dimers, the two monomers are in blue and gold. The two IN dimers (light and dark) are
related by a twofold symmetry.
doi:10.1371/journal.pone.0060734.g003
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tDNA and leading to reduced integration events as well as
inhibition of nonspecific integration.
To establish structure – function relationships we hypothesize
that the main structural and functional effects of INI1 on IN is
mediated through the INI1 integrase binding domain, which has
been shown to be the minimal sequence for the interaction of INI1
with IN [31]. INI1 has been shown to both increase [38,41,42]
and inhibit [43] viral replication. The two contradictory functions
of INI1, inhibition and activation probably occur at different times
during the infection cycle. Little is known about the timing of the
interaction of cellular proteins with IN. Assuming that INI1-IBD
interacts with IN in the same way as the full length protein, the
observation that a stable ternary complex between IN, LEDGF
and INI1-IBD can be formed suggests that the two cellular
proteins may interact with the PIC during the same temporal
window. The interaction of INI1 with the PIC is probably an early
event since it was shown that INI1 is incorporated in mature
virions [39], that HIV-1 infection triggers the nuclear export of
INI1 which associates with the incoming HIV-1 PICs [56] and
that INI1 is present in the reverse transcription complex [57]. The
fact that INI1 expression in a cell line deleted for the gene
encoding INI1 increases viral replication in a dose-dependent
manner [38] suggests that IN interacts with these newly produced
INI1 molecules. Taken together, these observations suggest that
the interaction between INI1-IBD and IN we observe in our
structure is likely to occur between reverse transcription and 39
processing and before nuclear translocation. After nuclear in-
ternalization, both INI1 and LEDGF are likely to stabilize the
highly flexible IN. LEDGF probably stabilizes the IN tetramer
while INI1 might prevent non-specific protein interactions and
auto-integration on the way to nucleosomes. Moreover, INI1, as
part of the SWI/SNF chromatin remodeling complex, is believed
to play a role in the control of viral integration through the
chromatin reorganization of the host genome [41]. Indeed, in vitro
experiments showed that stable nucleosomes reconstituted on
strongly positioning DNA sequences inhibit the integration of viral
DNA and that purified SWI/SNF complexes restore integration,
suggesting a coupling between nucleosome remodeling and
efficient HIV-1 integration [41]. Thus, SWI/SNF is thought to
promote integration in target nucleosomes through its unwinding
Figure 4. Superimposition of the IN/LEDGF/DNA and IN/LEDGF/INI1-IBD/DNA structures. A: Superimposition of the IN/LEDGF/DNA (grey)
and IN/LEDGF/INI1-IBD/DNA (blue) structures. B: DNA fitting. The spikes in the two structures unambigously revealed the DNA position. The DNA
(yellow) is fitted in the IN/LEDGF/INI1-IBD/DNA map (mesh representation) with a 40u rotation from its position in the IN/LEDGF/DNA map (surface
representation).
doi:10.1371/journal.pone.0060734.g004
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activity, by producing a suitable nucleosomal DNA for the strand
transfer reaction. We speculate that INI1 may be released from IN
during the nucleosome remodeling process in order to activate its
integration function. In contrast, after INI1 release, LEDGF is
likely to remain attached to IN in order to maintain its tetramer
organization and to enhance the efficiency of integration (Fig. 7).
In the cellular context, it has been shown that the IN-INI1 and
IN-LEDGF interactions are advantageous for viral infection. The
INI1 and LEDGF cellular proteins would have two major
functions in the early state of HIV-1 replication. One function
would be to target the PIC to chromatin and nucleosomes through
the PWWP domain of LEDGF and to perform nucleosome
remodeling through INI1, a part of the SWI/SNF complex. Their
second function would be a chaperon function. INI1 would
stabilize the PIC in the host cell, by transiently inhibiting the IN
enzymatic functions (39 processing and strand transfer) via capping
of the flexible N- and C-terminal parts of the IN tetramer, and
thus maintaining IN in a stable constrained conformation on the
route to nucleosomes. LEDGF would organize and stabilize an
active IN tetramer suitable for specific vDNA integration. Finally,
the structure presented in this work, provides the basis for the
development of a new type of inhibitor (conformational inhibitor),
which is able to block the structural changes of IN required to
perform its functions.
Supplementary data are available online: Figures S1–S11 and
Methods S1.
Materials and Methods
Production and Purification of HIV-1 IN, LEDGF and INI1
(174–289) (INI1-IBD)
The IN/LEDGF complex was produced and purified as
previously described [17]. HIS-tagged INI1 (174–289) was cloned
in pET expression plasmid and transformed in Escherichia coli
BL21(DE3) host strain (Novagen) containing pRARE plasmids
isolated from Rosetta DE3 strain (Novagen). After the INI1-IBD
purification described in methods S1, the IN/LEDGF buffer was
raised up to 2 M NaCl and 20 mM CHAPS. IN/LEDGF and
INI1-IBD were mixed at a 1:2 molar ratio, respectively, and
dialyzed against buffer B [50 mM HEPES pH 7.0, 500 mM
NaCl, 5 mM MgCl2, 2 mM b-mercaptoethanol]. The ternary
complex was concentrated using an Amicon Ultra-15 50 kDa
device (Millipore) and loaded at 1 mL/min onto a Superdex
200 HR gel filtration column (GE Healthcare) pre-equilibrated in
buffer B. Peak fractions were used directly for electron microscopy
and functional tests. Protein concentration was determined using
the Bradford colorimetric assay (Bio-Rad). The purity of the
complex was checked on SDS-PAGE and DNA contamination by
UV spectrum.
High-Mass MALDI ToF Mass Spectrometry Analysis
High-Mass MALDI mass spectra were obtained using
a MALDI-TOF equipped with HM2 TUVO High-Mass retrofit
system (CovalX AG, Zu¨rich, Switzerland). The High-Mass retrofit
system allows a sensitive detection (sub-mM) of macromolecules up
to 1500 kDa with low saturation. The instrument was operated in
the linear mode by applying an accelerating voltage of 20 kV and
a gain voltage set to 2.95 kV. Mass spectra were acquired by
averaging 300 shots (3 different positions into each spot and 100
shots per position). All subsequent mass spectra acquisitions were
performed by applying the same laser fluency before and after
cross-linking. Further information is provided in methods S1.
Fluorescence Correlation Spectroscopy
Fluorescence correlation spectroscopy (FCS) measurements
were performed with in-house setup [58,59], consisting of an
Olympus IX 71 microscope associated with a two-photon
excitation at 800 nm, provided by a mode-locked Ti:Sapphire
laser (Tsunami, Spectra Physics). Emitted photons were detected
with an Avalanche Photodiode (APD SPCM-AQR-14-FC,
PerkinElmer Optoelectronics). The normalized autocorrelation
function G(t) was calculated on line by a hardware correlator
(ALV 5000, ALV GmbH). Multiple FCS runs [60] of short
duration (5 s) were performed on solutions of viral DNA tagged
with Texas Red (vDNA-TXR), without and with IN/LEDGF.
The excitation power was about 5 mW at the sample, in order to
provide optimal signal/noise ratio and minimal probe photo-
bleaching [61]. The details of data processing are described in
methods S1.
Figure 5. Topology of the IN tetramer. A: View from the INI1-IBD side of the complex. B: View of the IN tetramer after removing the INI1-IBD
density. The two IN dimers (1 and 2) are related by a twofold axis perpendicular to the sheet. Each IN monomer (A and B) is represented in a different
color (blue and gold). The two monomers related by the two fold symmetry are represented in light and dark color (light blue for A1 and dark blue for
A2, light gold for B1 and dark gold for B2). The positions of the IN domains are indicated: Nt for the N-terminal domain, Cc for the catalytic core and
Ct for the C-terminal domain.
doi:10.1371/journal.pone.0060734.g005
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Determination of Binding Constants by Fluorescence
Anisotropy
Titration curves were performed in 384 well-plates, containing
20 mL of reaction mixtures composed of (i) 2 nM of a 40 bp
double strand DNA with the sequence of the U5 end of HIV-
1 DNA and 59 modified by 6-fluorescein and (ii) increasing
concentrations of IN/LEDGF or IN/LEDGF/INI1-IBD. Com-
petition experiments were done using non-modified U5 DNA and
non-modified 49 bp double strand DNA with a random sequence.
The final buffer contained 150 mM NaCl, 50 mM HEPES
pH 7.5, 5 mM MgCl2, 1 mM b-mercaptoethanol. After homog-
enization, the fluorescence anisotropy measurements were per-
formed for 3 minutes in triplicate on a PHERAstarPlus (BMGLab)
microplate reader at 20uC, using an excitation polarized
Figure 6. IN/LEDGF/INI1-IBD/DNA structure. A. INI1-IBD (pink) sits on the top of the complex and interacts with the C and N termini of the two
IN monomers B. An extension of INI1-IBD interacts with the C-terminus of the two monomers A. B. A 90u view sliced as shown by the dotted square in
figure A. C and D: two 90u views showing clearly the IN interacting domains with INI1.
doi:10.1371/journal.pone.0060734.g006
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wavelength of 470 nm and an emission wavelength of 520 nm.
Further information and the calculation of the dissociation
constant are provided in methods S1.
IN-LEDGF and IN-LEDGF-INI1-IBD 39 Processing Activity
Monitored by Fluorescence Anisotropy
The reaction was done in a 96 well-plate. One well contained
100mL of reaction mix composed of 10 mM NaCl, 25 mM BisTris
pH 6.5, 10 mM MgCl2, 5 mM DTT, 50 nM DNA and 200 nM
of protein complex. The DNA is a 40 base pair double strand
DNA, mimicking the U5 end of HIV-1 DNA and 39 modified by
6-fluorescein. After homogenization, 50mL of paraffin oil was
added on the top of the well to avoid evaporation. Fluorescence
anisotropy measurements were performed on a PHERAstarPlus
(BMGLab) spectrophotofluorimeter with an excitation polarized
wavelength of 470 nm. The reaction was monitored for 6 hours at
37uC. Further information is provided in methods S1.
In vitro Concerted Integration Assay
Standard concerted integration reactions were performed as
described previously [41,62], with some modifications. Briefly,
purified HIV-1 IN (0.1 to 12.5 mM in IN monomer), IN/LEDGF
complex (0.1 to 12.5 mM in IN monomer) or IN/LEDGF/INI1-
IBD complex (12.5 mM in IN monomer) was pre-incubated with
both a 246 bp 59-end-labeled donor DNA (15 ng), containing the
processed U3 and U5 LTR sequences and a SupF gene, and the
target DNA plasmid pBSK+ (150 ng) at 0uC for 20 min in a total
volume of 5 ml. Then, the reaction mixture (20 mM HEPES,
pH 7.5; 10 mM DTT; 10 mM MgCl2; 15% DMSO; 8% PEG,
30 mM NaCl) was added and the reaction proceeded for 120 min
at 37uC in a total volume of 10 mL. Incubation was stopped by
adding a phenol/isoamyl alcohol/chloroform mix (24/1/25 v/v/
v). The aqueous phase was loaded on a vertical 1% agarose gel in
the presence of 1% bromophenol blue and 1 mM EDTA. After
separation of the products, the gel was treated with 5% TCA for
20 min, dried and autoradiographed. All IN activities were
quantified by scanning of the bands (half site plus full site
integration products) after gel electrophoresis and autoradiography
using the Image J software. Both target DNA and donor plasmids
were kind gifts from Dr. K Moreau (Universite´ Claude Bernard-
Lyon I, France). The target corresponds to the pBSK+ plasmid
(Stratagene, La Jolla, California), carrying the zeocin resistance-
encoding gene.
The Full Site Integration (FSI) reaction was additionally
quantified by cloning the integration products into bacteria using
the same protocol as described previously [62]. Briefly, after
concerted integration, the products were purified on a DNA
purification system column (Promega), as described by the supplier
and then introduced into a MC1060/P3 E. coli strain which
contained ampicillin-, tetracycline- and kanamycin-resistance
genes. Both ampicillin- and tetracycline-resistance genes carry an
amb mutation. These proteins are thus expressed only in the
presence of supF gene products. Integration clones carrying the
supF gene were therefore selected in the presence of 40 mg/ml
ampicillin, 10 mg/ml tetracycline and 15 mg/ml kanamycin. The
integration loci structure was determined by isolating plasmids
from quadruple-resistant colonies and PCR sequencing (ABI
Prism big dye terminator cycle sequencing ready reaction kit,
Applied Biosystems) using the U3 primer (59-TATGGAAGGGC-
TAATTCACT-39) and the U5 primer (59-TATGCTAGA-
GATTTTCCACA-39).
Electron Microscopy and Image Processing
For negatively stained samples, the purified IN/LEDGF/INI1-
IBD complexes were diluted to a concentration of 20 mg/mL in
buffer B and crosslinked with 0.1% glutaraldehyde for 5 sec.
10 mL of this preparation were placed on a 10 nm thick carbon
film treated by a glow discharge in air. After two minutes of
adsorption, the specimen was negatively stained with a 2% (w/v)
uranyl acetate solution. Images were recorded under low-dose
conditions on a transmission electron microscope (TEM, Philips
CM120), equipped with a LaB6 cathode and operating at 100 kV
at 45,000 X magnification on a Pelletier cooled slow scan CCD
Figure 7. Structure-function analysis. A. IN/LEDGF/vDNA structure in the 39 processing conformation. B. In the IN/LEDGF/INI1-IBD/vDNA
complex, INI1-IBD caps the surface of the complex and blocks IN in an intermediate conformation, as shown by the position of the viral DNA (yellow).
C. IN/LEDGF/vDNA/tDNA structure in the strand transfer conformation after release of INI1 and binding to the target DNA (red).
doi:10.1371/journal.pone.0060734.g007
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camera (Model 794, Gatan, Pleasanton), which resulted in a pixel
spacing of 0.37 nm on the object.
For frozen hydrated samples, the complexes were diluted and
adsorbed as described above, but were vitrified using an
automated plunger equipped with a temperature and humidity
controlled chamber (Vitrobot FEI). Images were recorded under
low-dose conditions (15–20 e2/A˚2) on a cryo-TEM equipped with
a field emission gun operating at 200 kV (Tecnai F20, FEI) and
with a side-entry cold stage working at a temperature of 2172uC.
The image data set was acquired on photographic plates (SO163,
Eastman-Kodak) at 50,000 X magnification and at defocus values
ranging from 2.7 to 3.9 mm. The micrographs were digitized using
a drum scanner (Primescan D7100, Heidelberg) to obtain a final
pixel spacing of 0.2 nm. Examples of the initial images are shown
in figure S10. Class average images obtained after reference-free
classification and the corresponding re-projections of the final 3-D
model fitting are shown in figure S11. Image analysis is described
in methods S1.
Model Building and Fitting
Flexible fitting of the atomic structures in the EM maps was
done using normal mode analysis [63,64]. Normal mode flexible
and rigid body fitting were performed with the procedure
described in methods S1, using NORMA [63] and URO [65].
Regularization of the structure was done with REFMAC [66].
Difference maps were calculated using CCP4 [67] and COOT
[68] and map superposition was performed with UCSF chimera
[69]. Figures were produced with UCSF chimera and Pymol [70].
Further information is provided in methods S1.
Supporting Information
Figure S1 Superimposition of IN catalytic core domain
structures. A. Superimposition of the structures of the IN
catalytic core domain in the Maedi visna virus (MVV) [71] in pink,
the Prototype foamy virus (PVF) [72] in cyan, the Human
immunodeficiency virus type 2 (HIV-2) [73] in yellow and the
Human immunodeficiency virus type 1 (HIV-1) [12] in red. The
N-terminal domains are circled in blue. B. Superimposition of the
structures of the IN catalytic core domain of the Rous sarcoma
virus (RSV) [74] in gold, HIV-1 [11] in red and PVF [72] in cyan.
The C-terminal domains are circled in red.
(TIF)
Figure S2 EM structure of PFV integrase. (A, B, C) Three
perpendicular surface representation of the EM 3-D envelope of
the PFV integrase. (D) Fitting of the PFV X-ray structure in the
EM map. (E) Resulting structure after normal mode flexible
fitting. The details of the structure solving are described in
supplemental protocols. (F) EM Structures of the IN/LEDGF
complex in grey and the PFV IN tetramer in gold.
(TIF)
Figure S3 Comparison of the HIV-1 and PFV intasome.
A. Superimposition of the structures of the IN catalytic domain in
the HIV-1 IN-LEDGF-DNA complex (blue) [17] and the PFV IN-
DNA complex (gold) [16], showing that the viral DNA is collinear
in the two complexes. B. Same superimposition showing that the
target DNA comes from opposite sides in PFV and HIV-1. C.
Topology of the organization of IN monomers in gold-yellow for
PFV and blue for HIV-1. D. Schema of the tetramer organization
in PFV and HIV1.
(TIF)
Figure S4 Domain organization of INI1. Domain organi-
zation of INI1 and position on the sequence of the 174–289
fragment used in this study.
(TIF)
Figure S5 Purification and characterization of the IN/
LEDGF/INI1-IBD complex. Purification and characteriza-
tion: A. IN, LEDGF and INI1-IBD are purified separately. IN and
LEDGF are mixed together and the complex is formed by
removing the solubilizing agents by dialysis. The complex is then
purified on a GST affinity column. The GST tag is cut by the P3C
protease and removed on a GST affinity column. The salt
concentration is then increased and the IN/LEDGF complex is
mixed with INI1-IBD. The CHAPS and salt are then decreased by
dialysis. Finally, the IN/LEDGF/INI1-IBD complex is purified on
a gel filtration column. The Coomassie blue stained SDS-PAGE
demonstrates the homogeneity of the IN/LEDGF/INI1-IBD
complex. B. IN/LEDGF/INI1-IBD complex analysis by High-
Mass MALDI mass spectrometry. C. The same analysis after
reaction with cross-linking agents. A major peak of (IN)4-
(LEDGF)2-(INI1-IBD)2 was observed.
(TIF)
Figure S6 Determination by two-photon FCS of the
binding stoichiometry of U5 vDNA-TXR duplexes to IN/
LEDGF. Determination by two-photon FCS of the binding
stoichiometry of U5 vDNA-TXR duplexes to IN/LEDGF. A:
Autocorrelation curves of U5 vDNA-TXR (40 nM) in the absence
(black) and the presence (red) of 26 nM IN/LEDGF are shown,
together with their fits (solid line) using eq. 1 and 2 in methods S1
respectively. B: Brightness distribution for U5 vDNA-TXR
(40 nM) in the absence (black bar) and in the presence of IN/
LEGDF (red bar). The histogram was obtained by sorting the
measured brightness values (n<60) into different classes of 0.2 kHz
in width. The median value is about 0.77 kHz for the free U5
vDNA-TXR duplexes and about 1.5 kHz for the U5 vDNA-
TXR/IN/LEDGF complexes. C: Normalization of the autocor-
relation curves of figure 2A.
(TIF)
Figure S7 Gel based 39 processing assay and quantifi-
cation. A: Determination of the 39 processing activity for the IN/
LEDGF and IN/LEDGF/INI1-IBD complex. The reaction was
done using a 59 6FAM modified U5 dsDNA of 40 base pairs. For
the IN/LEDGF complex we clearly see the vanishing of the
40 mer DNA and the apparition of the band corresponding to the
38 mer DNA, whereas in the presence of INI1 there is no
difference with the control (DNA alone), confirming the inhibitory
effect of INI1-IBD. The reaction mixture contained 200 mL of
reaction mix composed of 23 mM NaCl, 25 mM BisTris pH 6.5,
10 mM MgCl2, 5 mM DTT, 125 nM DNA and 500 nM of
protein complex. The reaction was stopped at 0, 60, 240 and
360 mn by the addition of 200 mL of STOP buffer (25 mM Tris/
HCl pH 7.5, 25 mM EDTA, 0,125 mg/ml Glycogen, 800 mM
NaOAc). The DNA was then precipitated by adding 1 ml of
EtOH and kept at 220u overnight. After centrifugation, the DNA
pellets were resuspended in 40 mL of loading dye (95%
formamide; 20 mM EDTA; 0.1% SDS; 0.025% Bromophenol
Blue; 0.025% Xylene Cyanol). The samples wereloaded on a 20%
polyacrylamide, 7 M urea denaturing DNA gel and the migration
was performed overnight at 500 V. The gel was then scanned on
a Typhoon 8600 imager (Molecular Dynamics). B: Quantification
of the bands on the gel in S7A. Band intensities were quantified
using the ImageJ software. For each lane, the relative proportion
of processed and non-processed DNA was calculated and
represented as a percentage of the total lane intensity. It clearly
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shows the inhibition of the 39 processing in the presence of INI1-
IBD.
(TIF)
Figure S8 Quantification of the integration assay shown
in Fig. 2D. A: Intensity of the load band on the autoradiography
of the gel shown in figure 2d. B: Intensity of the d/d (green) linear
FSI (red) and HIS+FSI (blue) bands on the autoradiography of the
gel shown in figure 2d. In the presence of INI1-IBD, a reduction of
the integration events was observed as well as an inhibition of by-
product formation such as d/d or linear FSI molecules.
(TIF)
Figure S9 Resolution determination. Fourier Shell Corre-
lation Function obtained by comparing two distinct IN/LEDGF/
INI1-IBD/DNA reconstructions obtained by splitting the data set
in two. The 0.5 FSC criterion gives a resolution of 24 A˚, whereas
the Rosenthal and Henderson criterion (0.145 FSC) gives
a resolution of 18 A˚.
(TIF)
Figure S10 Electron micrograph of unstained com-
plexes. Electron micrograph of unstained complexes recorded
at low temperature on a cryo electron microscope operating at
200 kV. The particles are circled in the right panel.
(TIF)
Figure S11 Class averages and re-projections of the
final 3-D model. Rows 1, 3, 5: Gallery of frozen hydrated class
averages obtained after reference-free classification and three
cycles of alignment/classification that used the best class averages
of the previous classification as new alignment references. Rows
2, 4, 6: Re-projections of the final 3-D model with the best fit to
the initial class averages.
(TIF)
Methods S1 Detailed information on the experimental
methods used (Production and Purification, High-Mass
MALDI ToF, Fluorescence Correlation Spectroscopy,
Fluorescence Anisotropy, Cryo-electron Microscopy) is
provided.
(PDF)
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